An adverse drug response (ADR) is a negative or damaging reaction that occurs after taking a medication or medication combination under everyday circumstances and is thought to be caused by the medication. Usually, an ADR calls for stopping the medication or lowering the dose. An adverse reaction is any injury that happens to a patient while they are taking medication, regardless of whether the medication is thought to be the cause or not. Any impact medicine has that is not the intended therapeutic effect—whether positive, negative, or neutral—is considered a side-effect. Although the terms "side-effect" and "ADR" are sometimes used interchangeably, the former generally denotes a less negative, predictable impact that may not even necessitate stopping therapy (e.g., ankle edema with vasodilators.) When a medicine's dosage or plasma concentration exceeds the therapeutic range, whether purposefully or inadvertently, it can lead to undesirable consequences. These unfavourable effects are referred to as drug toxicity (drug overdose). Addiction or dependency, major physiological harm (such as damage to the kidneys, liver, or heart), psychological impairment (abnormal behaviour patterns, hallucinations, memory loss), or even death can result from the misuse of recreational or therapeutic substances.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia